Molecular Diagnosis & Therapy

Molecular Diagnosis & Therapy(英文缩写 MOL DIAGN THER),ISSN 1177-1062,eISSN 1179-2000 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

发文量统计区间：2025-09-21 至 2026-09-21，按本站收录文献的发表日期统计。

指标来源：jcr_cas_ifqb

历年影响因子趋势

Molecular Diagnosis & Therapy 最新收录文献

1. JCR分区: Q1 CAS分区: B3 影响因子: 5.8

   1. Orca-T: First Approval.

   PMID:

   42753097

   作者:

   Hannah A Blair

   期刊:

   Molecular diagnosis & therapy PubMed

   DOI:

   10.1007/s40291-026-00882-1

   日期:

   2026-09-17

   Allogeneic regulatory T cell immunotherapy with haematopoietic stem and progenitor cells (HSPC) and T cells-vldq, hereafter referred to as Orca-T (TREGZI), has been developed by Orca Bio under license from Stanford University for the prevention of chronic graft-versus-host disease (cGVHD). On 30 Jun…

   查看详情PubMed 原文记录
2. JCR分区: Q1 CAS分区: B3 影响因子: 5.8

   2. Rapid Ex Vivo Visualization of Laryngeal Tumors Using a Sprayable pH-Activatable Fluorophore.

   PMID:

   42726450

   作者:

   Daan G J Linders, Sebastiaan W R Dalmeijer, Bo E Zweedijk, Hamed Abbasi, Danielle Boldewijn, Sjors A Koppes, Bernd Kremer, Jacobus Burggraaf, Denise E Hilling, Joost R van der Vorst, Jinhui Ser, Satoshi Kashiwagi, Maged Henary, Jeroen C Jansen, Alexander L Vahrmeijer, Hak Soo Choi, Stijn Keereweer

   期刊:

   Molecular diagnosis & therapy PubMed

   DOI:

   10.1007/s40291-026-00878-x

   日期:

   2026-09-11

   Achieving clear resection margins (> 5 mm) is critical during laryngeal and hypopharyngeal tumor resection, as positive margins are associated with reduced disease-specific survival. Near-infrared (NIR) fluorescence imaging has emerged as a valuable tool for intraoperative margin assessment by enabl…

   查看详情PubMed 原文记录
3. JCR分区: Q1 CAS分区: B3 影响因子: 5.8

   3. Amyloid-β PET Radioligands in Alzheimer's Disease: From Plaque Detection to Biomarker-Guided Patient Stratification and Therapeutic Monitoring.

   PMID:

   42720909

   作者:

   Simone Lista, Luca Filippi, Enzo Emanuele, Susana López-Ortiz, Giusy Ylenia Cisale, Piercarlo Minoretti, Francesco Garaci, Alejandro Santos-Lozano

   期刊:

   Molecular diagnosis & therapy PubMed

   DOI:

   10.1007/s40291-026-00879-w

   日期:

   2026-09-10

   Amyloid-β (Aβ) positron emission tomography allows direct in vivo visualization of insoluble fibrillar Aβ deposition and has been used to detect Alzheimer's disease pathology across the clinical continuum, from preclinical stages to overt dementia. Aβ tracers progressed from the prototypical [C]Pitt…

   查看详情PubMed 原文记录
4. JCR分区: Q1 CAS分区: B3 影响因子: 5.8

   4. Anbalcabtagene Autoleucel: First Approval.

   PMID:

   42704424

   作者:

   Arnold Lee

   期刊:

   Molecular diagnosis & therapy PubMed

   DOI:

   10.1007/s40291-026-00872-3

   日期:

   2026-09-07

   Anbalcabtagene autoleucel (RIMQARTO) is a CAR T therapy that includes CAR T cells with dual PD-1 and TIGIT downregulation to mitigate T cell exhaustion. It is being developed by Curocell Inc. for the treatment of diffuse large B-cell lymphoma, acute lymphoblastic leukaemia and autoimmune diseases, w…

   查看详情PubMed 原文记录
5. JCR分区: Q1 CAS分区: B3 影响因子: 5.8

   5. Development of a Point-of-Care Recombinase Polymerase Amplification Assay for Detection of Neisseria gonorrhoeae and Ceftriaxone-Resistance Associated penA Allele 60.001.

   PMID:

   42498842

   作者:

   Xia Sun, Ying Fu, Yi Liu, Qiongyao Liu, Luxia Chen, Jiang Zhu, Xu'ai Lin, Hao Cheng, Stijn van der Veen

   期刊:

   Molecular diagnosis & therapy PubMed

   DOI:

   10.1007/s40291-026-00868-z

   日期:

   2026-09-01

   Neisseria gonorrhoeae is a global public health threat, exacerbated by the rapid dissemination of ceftriaxone-resistant strains harboring penA allele 60.001. Current diagnostics are limited by long turnaround times, reliance on thermal cycling equipment, and poor suitability for resource-limited set…

   查看详情PubMed 原文记录
6. JCR分区: Q1 CAS分区: B3 影响因子: 5.8

   6. Multidisciplinary and Personalized Molecular Diagnosis to Solving Sudden Death During Sport.

   PMID:

   42481905

   作者:

   Andrea Costantino, Oscar Campuzano, Fabio Vaiano, Eleonora Nardi, Alexandra Dimitrova, Andrea Greco, Estefanía Martínez-Barrios, Vincenzo Arena, Hannah Jarvis, Georgia Sarquella-Brugada, Ramon Brugada, Antonio Oliva, Simone Grassi

   期刊:

   Molecular diagnosis & therapy PubMed

   DOI:

   10.1007/s40291-026-00867-0

   日期:

   2026-09-01

   Sudden cardiac death is the leading cause of death among athletes during exercise. These events are devastating for both the family and society, especially when they occur in children and young adults. Some of these unexpected deceases occur in athletes who carry genetic alterations that predispose …

   查看详情PubMed 原文记录
7. JCR分区: Q1 CAS分区: B3 影响因子: 5.8

   7. Decoding and Overcoming Temozolomide Resistance Through CRISPR/Cas Technologies.

   PMID:

   42455481

   作者:

   Bárbara S Marques, Maria Mendes, José Luís Alves, Alberto Pais, Carla Vitorino

   期刊:

   Molecular diagnosis & therapy PubMed

   DOI:

   10.1007/s40291-026-00864-3

   日期:

   2026-09-01

   Intrinsic and acquired resistance to temozolomide (TMZ), the standard chemotherapeutic agent for glioblastoma (GBM), is highly common and results in poor clinical outcomes. This review highlights the emerging dual role of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated …

   查看详情PubMed 原文记录
8. JCR分区: Q1 CAS分区: B3 影响因子: 5.8

   8. Marnetegragene Autotemcel: First Approval.

   PMID:

   42455480

   作者:

   Simon Fung

   期刊:

   Molecular diagnosis & therapy PubMed

   DOI:

   10.1007/s40291-026-00863-4

   日期:

   2026-09-01

   Marnetegragene autotemcel (KRESLADI™), an autologous stem cell-based gene therapy that adds functional copies of the ITGB2 gene to haematopoietic stem cells, was developed by Rocket Pharmaceuticals for the treatment of leukocyte adhesion deficiency-I (LAD-I). In March 2026, marnetegragene autotemcel…

   查看详情PubMed 原文记录
9. JCR分区: Q1 CAS分区: B3 影响因子: 5.8

   9. Multiplex RT-PCR-Based Sequencing Assay to Detect Kidney Cancer-Specific Splice Variants in Tumor Tissues and Plasma Cell-Free RNAs.

   PMID:

   42410176

   作者:

   Kapil K Avasthi, Kendrick H Yim, Youngchul Kim, Paola M Ramos Echevarria, Liz M Darst, Nicholas Abreu, Kelly P Zea, Mitchell T Hayes, Aram Vosoughi, Brandon J Manley, Liang Wang

   期刊:

   Molecular diagnosis & therapy PubMed

   DOI:

   10.1007/s40291-026-00865-2

   日期:

   2026-09-01

   Clear cell renal cell carcinoma (ccRCC) lacks sensitive molecular biomarkers for early detection of disease recurrence and monitoring. Recurrent splice variants (SVs) offer promising diagnostic potential for capturing tumor-specific signals in circulating blood. In this study, we report a multiplex …

   查看详情PubMed 原文记录
10. JCR分区: Q1 CAS分区: B3 影响因子: 5.8

    10. Individualized Longitudinal ctDNA Monitoring in Melanoma Using Multiplexed USE-PCR.

    PMID:

    42393480

    作者:

    Annalara G Fischer, Hunter A Miller, Melissa B Hall, Kavitha Yadannapudi, Lucien Jacky, John Alvarado, Aaron Aguiar, Nathaniel Clark, Paul Belitz, Jeremy Myslinski, Paul Flook, Jerrod J Schwartz, Mark W Linder

    期刊:

    Molecular diagnosis & therapy PubMed

    DOI:

    10.1007/s40291-026-00862-5

    日期:

    2026-09-01

    Circulating tumor DNA enables longitudinal monitoring in cancer, but current sequencing-based assays are limited by cost, turnaround time, performance in difficult genomic regions, and infrequent sampling. Universal Signal Encoding PCR (USE-PCR) is a highly multiplexed digital PCR chemistry that ena…

    查看详情PubMed 原文记录